Skip to content

Author

Musa Harun Göçmen

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Clinical Effectiveness and Tolerability of Apremilast in Moderate-to-Severe Plaque Psoriasis: Insights from Real-World Practice Moderate-to-Severe Plaque Psoriasis: Insights from Real-World Practice

Apremilast is an oral phosphodiesterase-4 inhibitor approved for the treatment of moderate-to-severe plaque psoriasis. Although its efficacy and safety have been demonstrated in randomized controlled trials, real-world data remain limited. This study aimed to evaluate the real-world effectiveness and safety of apremila...

M. Turkmen, Musa Harun Göçmen, Emre Sarıkaya et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.